Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders
about
An overview of diabetes management in schizophrenia patients: office based strategies for primary care practitioners and endocrinologistsIncreased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.Low-Dose of Bergamot-Derived Polyphenolic Fraction (BPF) Did Not Improve Metabolic Parameters in Second Generation Antipsychotics-Treated Patients: Results from a 60-days Open-Label Study.Real-world risk of diabetes with antipsychotic use in older New Zealanders: a case-crossover study.Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?
P2860
Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacological mechanisms und ...... otics with metabolic disorders
@ast
Pharmacological mechanisms und ...... otics with metabolic disorders
@en
Pharmacological mechanisms und ...... otics with metabolic disorders
@nl
type
label
Pharmacological mechanisms und ...... otics with metabolic disorders
@ast
Pharmacological mechanisms und ...... otics with metabolic disorders
@en
Pharmacological mechanisms und ...... otics with metabolic disorders
@nl
prefLabel
Pharmacological mechanisms und ...... otics with metabolic disorders
@ast
Pharmacological mechanisms und ...... otics with metabolic disorders
@en
Pharmacological mechanisms und ...... otics with metabolic disorders
@nl
P2093
P2860
P356
P1476
Pharmacological mechanisms und ...... otics with metabolic disorders
@en
P2093
P2860
P356
10.12865/CHSJ.40.01.02
P407
P577
2014-01-01T00:00:00Z